Q2 consolidated profit rises while standalone loss narrows after restatement

Results restatedRevenue growth above 20%EBITDA margin expansionResults View source PDF Explain this filing

LYKALABS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-2.0%Reaction day

₹76.60

prior close

—

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+1.4%-3.4% vs market

Pharmaceuticals peers, median of 174sector+0.2%-2.2% vs sector

On the reaction day the stock moved 3.4 pts less than Nifty Microcap 250 and 2.2 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

—

10m

—

15m

—

30m

—

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-2.0+1.4-3.4+0.2-2.2

Next day

-1.3+1.7-3.0+0.6-2.0

-2.0+3.9-5.9+1.6-3.6

+0.6+5.1-4.4+2.3-1.7

+2.6pendingpending+2.2+0.4

—————

15d

—————

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 174Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

For Q2 ended 30 September 2026, consolidated revenue was Rs 4,419.95 lakh, up 4.5%, and profit after tax was Rs 127.11 lakh. Standalone revenue fell 4.3% to Rs 4,230.94 lakh, with a Rs 131.50 lakh loss. For the half-year, consolidated revenue rose 24.1% to Rs 8,650.89 lakh and profit after tax reached Rs 331.77 lakh from a Rs 221.81 lakh loss. Figures were restated after the Lyka Export merger; the review was unqualified.

Likely market impact

Consolidated profit supports sentiment, but the standalone loss and revenue fall may weigh on the stock. Merger restatement complicates comparisons.

By the numbersConsolidated · Q2 FY27 vs Q2 FY26

	Q2 FY27	Q2 FY26	Change
Revenue	₹44.20 Cr	₹36.66 Cr	+20.6%
Operating profit	₹0.45 Cr	−₹5.48 Cr	turned positive
Profit after tax	₹1.27 Cr	−₹3.21 Cr	turned positive
EBITDA margin	8.0%	-6.9%	+14.9 pp

From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income.